Featured Content

Hepatotoxic Effects of Lipid-Altering Agents 9/19/2012

Drug-induced liver damage is generally rare with this class, except in the case of sustained-release niacin.

Related Content

The Times They Are a-Changin'

A major health insurance company and pharmacy chain have partnered to offer patients with type 2 diabetes access to a new diabetes control program.


NCPA Partners With AADE to Expand Diabetes Counseling Options



Gestational Diabetes Mellitus

Gestational diabetes mellitus (GDM) is defined as any degree of glucose intolerance that occurs with pregnancy or is first discovered during pregnancy. GDM, which is the most common metabolic complication associated with pregnancy, imposes risks on both mother and fetus.


Pharmacotherapy of Diabetes in the Elderly

By optimizing medication use and reducing the risks of polypharmacy, the pharmacists plays a key role in decreasing morbidity and mortality in this patient population.


Optimal Management of Hyperglycemia in Hospitalized Patients

In the United States, the number of people diagnosed with diabetes is staggering.

1-800-222-1222 12/20/2011

The number of young children hospitalized or seen in the ER for ingesting a potentially toxic dose of medication has risen dramatically.


Reducing Pharmacy Technician Hospital Errors 12/20/2011

The pharmacy technician’s role is evolving and varies widely between the retail industry and hospital health systems, as well as from state to state.

FDA Warns of Unapproved Chelation Products 12/17/2010



Warnings for Gadolinium-Based Contrast Agents 10/20/2010



Aseptic Meningitis Risk With Use of Seizure Drug 9/20/2010



FDA Alerts Public About Danger of Skin-Numbing Products 3/18/2009



FDA Warns Against Dietary Supplement 3/18/2009



Advertisement